Our client is an integrated global pharmaceutical company with interests in APIs, global generics, and proprietary products and the sole licensed partner for the first globally registered COVID19 vaccine; Sputnik V, in India. The enterprise leverages its robust supply chain to accelerate the access to 200+ medicines across 80 countries worldwide. Moglix Business is partnering with the vaccine maker for its MRO procurement requirements across its 16 manufacturing plants in India to enable continuous supply, cost-competitiveness and quality assurance.
- Fragmented supplier base for MRO goods
- High inventory holding across all plants
- Volatile monthly MRO procurement spend